BioWorld Science

RSS

Opthea commences phase Ib/IIa study of OPT-302 in DME

Jan. 4, 2018

Expansion Therapeutics closes series A financing

Jan. 4, 2018

HDAC11 found to be a therapeutic target for multiple myeloma

Jan. 4, 2018

Acacia Pharma announces FDA acceptance of NDA filing for Baremsis

Jan. 4, 2018

VistaGen Therapeutics' AV-101 awarded FDA fast track designation

Jan. 4, 2018

FDA clears Palatin's IND for ulcerative colitis drug candidate

Jan. 4, 2018

Allergan exercises options for DARPin product candidates

Jan. 4, 2018

Sangamo, Pfizer to develop zinc finger protein gene therapy for ALS

Jan. 4, 2018

Simultaneous deletions of genes on two CDRs cooperate to induce B-cell abnormalities in mice

Jan. 4, 2018

Sarepta Therapeutics begins enrollment in phase I study of SRP-5051

Jan. 4, 2018